Clinical trial for prion disease drug candidate begins patient enrollment
A clinical trial for a new prion disease drug candidate has started enrolling human participants. The Broad Institute announced the start of the trial, which involves an experimental therapeutic. Prion diseases are currently untreatable and fatal neurodegenerative disorders. The trial represents a significant early step in the search for a potential treatment.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in